- Home
- PPBT vs ADN Comparison
PPBT vs ADN Comparison
Compare PPBT & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- ADN
- Stock Information
- Founded
- PPBT 2010
- ADN 2006
- Country
- PPBT Israel
- ADN United States
- Employees
- PPBT N/A
- ADN N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- PPBT Health Care
- ADN Utilities
- Exchange
- PPBT Nasdaq
- ADN Nasdaq
- Market Cap
- PPBT 6.2M
- ADN 6.6M
- IPO Year
- PPBT N/A
- ADN N/A
- Fundamental
- Price
- PPBT $2.33
- ADN $1.99
- Analyst Decision
- PPBT Strong Buy
- ADN
- Analyst Count
- PPBT 1
- ADN 0
- Target Price
- PPBT $33.00
- ADN N/A
- AVG Volume (30 Days)
- PPBT 251.5K
- ADN 80.2K
- Earning Date
- PPBT 08-15-2025
- ADN 08-19-2025
- Dividend Yield
- PPBT N/A
- ADN N/A
- EPS Growth
- PPBT N/A
- ADN N/A
- EPS
- PPBT N/A
- ADN N/A
- Revenue
- PPBT N/A
- ADN $670,000.00
- Revenue This Year
- PPBT N/A
- ADN $6,528.51
- Revenue Next Year
- PPBT N/A
- ADN N/A
- P/E Ratio
- PPBT N/A
- ADN N/A
- Revenue Growth
- PPBT N/A
- ADN N/A
- 52 Week Low
- PPBT $2.00
- ADN $1.71
- 52 Week High
- PPBT $13.95
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- PPBT 40.95
- ADN 43.59
- Support Level
- PPBT $2.35
- ADN $1.85
- Resistance Level
- PPBT $2.90
- ADN $2.50
- Average True Range (ATR)
- PPBT 0.17
- ADN 0.20
- MACD
- PPBT 0.00
- ADN 0.03
- Stochastic Oscillator
- PPBT 13.29
- ADN 21.54
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.